| Name |
Ikatibant Fresenius 30 mg otopina za injekciju u napunjenoj štrcaljki |
| Marketing Authorisation Number |
HR-H-144595233 |
| Active Substance |
ikatibant |
| Composition |
jedna napunjena štrcaljka od 3 ml sadrži ikatibantacetat koji odgovara količini od 30 mg ikatibanta jedan ml otopine sadrži 10 mg ikatibanta |
| Pharmaceutical Form |
otopina za injekciju u napunjenoj štrcaljki |
| Manufacturer |
Fresenius Kabi Austria GmbH, Graz, Austrija |
| Marketing Authorisation Holder |
Fresenius Kabi d.o.o., Radnička cesta 37a, Zagreb, Hrvatska |
| Marketing Authorisation Date |
12.01.2022 |
| MA Period of Validity |
12.01.2027 |
| Classification Number |
UP/I-530-09/20-01/146 |
| Registration Number |
381-12-01/70-22-04 |
| Prescription |
Medicinal product subject to medical prescription |
| Type of prescription |
Medicinal product on medical prescription for renewable delivery
|
| Distribution |
Supply through pharmacies (community) |
| Advertising to general public |
not allowed |
| ATC Code |
B06AC02 |
| Marketing status |
Not marketed |
| SmPC |
download |
| PL |
download |
| Public Assessment Report |
download
|
| Summary of risk management plan |
download |